Development of immunotoxins for potential clinical use in Hodgkin's disease

Annals of Oncology

Volumn 7, Issue SUPPL. 4, 1996, Pages

  Earth, S ^a   Schnell, R ^a   Diehl, V ^a   Engert, A ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Ber H2 saporin; DAB486IL 2; Hodgkin's disease; Immunotoxin; Review; RFT5 SMPT dgA

Indexed keywords

CD30 ANTIGEN; DIPHTHERIA TOXIN; HYBRID PROTEIN; IMMUNOTOXIN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ANTIBODY; MONOCLONAL ANTIBODY; RICIN; SAPORIN; TOXIN;

ANTINEOPLASTIC ACTIVITY; CANCER IMMUNOTHERAPY; CLINICAL TRIAL; CONFERENCE PAPER; HODGKIN DISEASE; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RECOMBINANT DNA TECHNOLOGY;

EID: 0029825903     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/7.suppl_4.s135     Document Type: Conference Paper

References (23)

1. De Vita VT, Molloy Hubbard S. Hodgkin's disease. N Engl J Med 1993; 328:560-5.
2. Longo IL, Young RC, Wesley M. Twenty years of MOPP therapy for Hodgkin's disease. J Clin Oncol 1986; 4:1295-306.
3. Valagussa P, Santora A, Fossati-Beloni F et al. Second acute leukemia and other malignancies following treatment for Hodgkin's disease. J Clin Oncol 1986; 4:830-7.
4. Ehrlich P. The relations existing between chemical constitution, distribution, and pharmacological action. Himmelweit F, Marquardt M, Dale H (eds): The Collected Papers of Paul Ehrlich, Vol I. Oxford: Pergamon Press 1956; 596-618.
5. Hsu SM, Jaffe ES. Leu Ml and peanut agglutinin stain the neoplastic cells of Hodgkin's disease. Am J Clin Pathol 1984; 82:29-32.
6. Hsu SM, Ho YS, Hsu PL. Effect of monoclonal antibodies anti-2H9, anti-IRac, and anti-HeFi-1 on the surface antigens of Reed-Sternberg cells. J Natl Cancer Inst 1987; 79:1091-7.
7. Stein H, Mason DY, Gerdes J et al. The expression of the Hodgkin's-disease-associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Sternberg-Reed cells and histocytic malignancies are derived from activated lymphoid cells. Blood 1985; 66:848-58.
8. Agnarsson BA, Kadin ME. The immunophenotype of ReedSternberg cells. A study of 50 cases of Hodgkin's disease using fixed frozen tissue. Cancer 1989; 63:2083-7.
9. Casey TT, Olson SJ, Cousar JB, Collins RD. Immunophenotypes of Reed-Sternberg cells: A study of 19 cases of Hodgkin's disease in plastic-embedded sections. Blood 1989; 74:5042-6.
10. Kennedy IC, Hart DN, Colls BM et al. Nodular sclerosing, mixed cellularity and lymphocyte-depleted variants of Hodgkin's disease are probable dendritic cell malignancies. Clin Exp Immunol 1989; 76:324-31.
11. Delabie J, Ceuppens JL, Vandenberghe P et al. The B7/BB1 antigen is expressed by Reed-Sternberg cells of Hodgkin's disease and contributes to the stimulating capacity of Hodgkin's disease-derived cell lines. Blood 1993; 82:2845-52.
12. Waldman TA. The interleukin-2 receptor. J Biol Chem 1991; 266:2681-4.
13. Taniguchi T, Minami Y. The IL-2/IL-2 receptor system: A current overview. Cell 1993; 73:5-8.
14. Cosman D, Lyman SD, Idzcrda RJ et al. A new cytokine receptor superfamily. TIBS 1990; 15:265-70.
15. Takeshita T, Asao H, Ohtani K et al. Cloning of the gamma chain of the human IL-2 receptor. Science 1992; 257: 37982.
16. Kreitman RJ, Pastan I. Recombinant single-chain immunotoxins against T and B cell leukemias. Leuk Lymph 1994; 13: 1-10.
17. Strauchen JA, Breakstone BA. IL-2 receptor expression in human lymphoid lesions. Immunohistochemical study of 166 cases. Am J Pathol 1987; 126:506-12.
18. Endo Y, Tsurugi K. RNA N-glycosidase activity of ricin A-chain. Mechanism of action of the toxic lectin ricin on eukaryotic ribosomes. J Biol Chem 1987; 262: 8128-30.
19. Lewis MS, Youle RJ. Ricin subunit association. Thermodynamics and the role of the disulfide bond in toxicity. J Biol Chem 1986; 261:11571-7.
20. Youle RJ, Murray GJ, Neville DM Jr. Studies on the galactosebinding site of ricin and the hybrid toxin ManoP-ricin. Cell 1981; 23:551-9.
21. Simmons BM, Stahl PD, Russell JH. Mannose receptor-mediated uptake of ricin toxin and ricin A chain by macrophages. Multiple intracellular pathways for A chain translocation. J Biol Chem 1986; 261:7912-20.
22. Eiklid K, Olsnes S, Pihl A. Entry of lethal doses of abrin, ricin and modeccin into the cytosol of HeLa cells. Exp Cell Res 1980; 126:321-6.
23. Byers VS, Baldwin RW. Therapeutic strategies with monoclonal antibodies and immunoconjugates. Immunol 1988; 65: 329-35.